Matt Meyanathan

Matt Meyanathan has a diverse work experience in the healthcare industry. Matt is currently working as a Solutions Lead, Oncology Care at Transcarent since 2022. Prior to that, they worked at Project Ronin from 2020 to 2022, where they were involved in strategy and business development, focusing on growth and new market development. Before that, Matt worked at BluePath Health as a Healthcare Strategy professional from 2013 to 2020. Matt also had a role as a Consultant at Health Evolution Partners from 2011 to 2013. In addition, they gained research experience as a Research Intern at the Entrepreneurship Centre, National University of Singapore in 2010. Matt started their career as a Process Quality Engineer, New Product Development at Abbott Laboratories from 2006 to 2009.

Matt Meyanathan completed their Bachelor's degree in Mechanical Engineering at Queen's University from 2002 to 2006. Subsequently, they pursued an MBA from the University of Toronto from 2009 to 2011.